Edwin DeJesus, MD

Medical Director
Orlando Immunology Center, University of Central Florida College of Medicine
Orlando, FL, United States

Disclosure information not submitted.

Presentation(s):

• 172 - The First Proof-of-Concept Clinical Trial of an HIV-1 Allosteric Integrase Inhibitor, Pirmitegravir (STP0404)

  Monday, October 20, 2025
  1:57 PM - 2:09 PM US ET